FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000902862> ?p ?o ?g. }

• W2000902862 endingPage "226" @default.
• W2000902862 startingPage "221" @default.
• W2000902862 abstract "Background Dermatomyositis (DM) is an inflammatory connective tissue disorder well recognized as a paraneoplastic syndrome in adults. Objective The objective of this study was to assess the prognosis of DM associated with malignant melanoma (MM). Patients and methods We systematically searched databases (PubMed, MEDLINE, and WEB OF SCIENCE) for articles reporting the concurrence of DM and MM. For the literature study, time of onset of DM in relation to diagnosis of MM (before, concomitant with, or after), stage of MM after restaging (according to the American Joint Committee on Cancer [AJCC] guidelines, 2001), and survival time after diagnosis of DM were recorded. Survival time studies and univariate statistical analyses were performed. Furthermore, we present our own clinical case of a patient with DM concomitantly occurring with regional lymph node metastasis of MM. Results In 5 cases DM occurred before, in 6 cases concomitantly with, and in 6 cases after progression of MM. Univariate analysis identified the AJCC stage of MM as a significant prognostic factor. Gender, age, and the time interval between onset of DM and progression of melanoma were unrelated. The 1-year actuarial survival rate was 0% for patients with DM when occurring with MM at stage IV and 60% when occurring with MM at stage III (P < .05). The estimated mean survival time was 6.6 months for patients with MM stage IV and 57 months for stage III. Limitations The conclusions from this study are limited by the relatively small number of articles that reported the association of MM and DM. Conclusion DM occurring in patients with MM at stage IV is connected with an extremely poor prognosis, whereas the few reported patients with DM and MM at stage III, including our case, have a prognosis similar to stage III patients without DM. Dermatomyositis (DM) is an inflammatory connective tissue disorder well recognized as a paraneoplastic syndrome in adults. The objective of this study was to assess the prognosis of DM associated with malignant melanoma (MM). We systematically searched databases (PubMed, MEDLINE, and WEB OF SCIENCE) for articles reporting the concurrence of DM and MM. For the literature study, time of onset of DM in relation to diagnosis of MM (before, concomitant with, or after), stage of MM after restaging (according to the American Joint Committee on Cancer [AJCC] guidelines, 2001), and survival time after diagnosis of DM were recorded. Survival time studies and univariate statistical analyses were performed. Furthermore, we present our own clinical case of a patient with DM concomitantly occurring with regional lymph node metastasis of MM. In 5 cases DM occurred before, in 6 cases concomitantly with, and in 6 cases after progression of MM. Univariate analysis identified the AJCC stage of MM as a significant prognostic factor. Gender, age, and the time interval between onset of DM and progression of melanoma were unrelated. The 1-year actuarial survival rate was 0% for patients with DM when occurring with MM at stage IV and 60% when occurring with MM at stage III (P < .05). The estimated mean survival time was 6.6 months for patients with MM stage IV and 57 months for stage III. The conclusions from this study are limited by the relatively small number of articles that reported the association of MM and DM. DM occurring in patients with MM at stage IV is connected with an extremely poor prognosis, whereas the few reported patients with DM and MM at stage III, including our case, have a prognosis similar to stage III patients without DM." @default.
• W2000902862 created "2016-06-24" @default.
• W2000902862 creator A5046907899 @default.
• W2000902862 creator A5047040974 @default.
• W2000902862 creator A5063249836 @default.
• W2000902862 creator A5070142178 @default.
• W2000902862 creator A5079571425 @default.
• W2000902862 creator A5088223855 @default.
• W2000902862 date "2006-02-01" @default.
• W2000902862 modified "2023-10-16" @default.
• W2000902862 title "Dermatomyositis associated with malignant melanoma—A marker of poor prognosis?" @default.
• W2000902862 cites W1968195717 @default.
• W2000902862 cites W1970690105 @default.
• W2000902862 cites W1971866649 @default.
• W2000902862 cites W1981592931 @default.
• W2000902862 cites W1992087022 @default.
• W2000902862 cites W2009375860 @default.
• W2000902862 cites W2013441795 @default.
• W2000902862 cites W2020002965 @default.
• W2000902862 cites W2032026474 @default.
• W2000902862 cites W2047509702 @default.
• W2000902862 cites W2051259062 @default.
• W2000902862 cites W2052305452 @default.
• W2000902862 cites W2058130671 @default.
• W2000902862 cites W2065345123 @default.
• W2000902862 cites W2066214958 @default.
• W2000902862 cites W2069276868 @default.
• W2000902862 cites W2074391357 @default.
• W2000902862 cites W2074895307 @default.
• W2000902862 cites W2093808149 @default.
• W2000902862 cites W2114849067 @default.
• W2000902862 cites W2117436899 @default.
• W2000902862 cites W2119822961 @default.
• W2000902862 cites W2131365547 @default.
• W2000902862 cites W2131371034 @default.
• W2000902862 cites W2165911231 @default.
• W2000902862 cites W2314311014 @default.
• W2000902862 cites W3168760501 @default.
• W2000902862 cites W4210496182 @default.
• W2000902862 cites W4248290207 @default.
• W2000902862 cites W4250479993 @default.
• W2000902862 cites W4252297811 @default.
• W2000902862 cites W4322702790 @default.
• W2000902862 doi "https://doi.org/10.1016/j.jaad.2005.10.026" @default.
• W2000902862 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16443051" @default.
• W2000902862 hasPublicationYear "2006" @default.
• W2000902862 type Work @default.
• W2000902862 sameAs 2000902862 @default.
• W2000902862 citedByCount "26" @default.
• W2000902862 countsByYear W20009028622013 @default.
• W2000902862 countsByYear W20009028622014 @default.
• W2000902862 countsByYear W20009028622015 @default.
• W2000902862 countsByYear W20009028622016 @default.
• W2000902862 countsByYear W20009028622020 @default.
• W2000902862 countsByYear W20009028622021 @default.
• W2000902862 countsByYear W20009028622022 @default.
• W2000902862 crossrefType "journal-article" @default.
• W2000902862 hasAuthorship W2000902862A5046907899 @default.
• W2000902862 hasAuthorship W2000902862A5047040974 @default.
• W2000902862 hasAuthorship W2000902862A5063249836 @default.
• W2000902862 hasAuthorship W2000902862A5070142178 @default.
• W2000902862 hasAuthorship W2000902862A5079571425 @default.
• W2000902862 hasAuthorship W2000902862A5088223855 @default.
• W2000902862 hasConcept C121608353 @default.
• W2000902862 hasConcept C126322002 @default.
• W2000902862 hasConcept C143998085 @default.
• W2000902862 hasConcept C144301174 @default.
• W2000902862 hasConcept C146357865 @default.
• W2000902862 hasConcept C151730666 @default.
• W2000902862 hasConcept C2777658100 @default.
• W2000902862 hasConcept C2778751314 @default.
• W2000902862 hasConcept C2779384505 @default.
• W2000902862 hasConcept C38180746 @default.
• W2000902862 hasConcept C502942594 @default.
• W2000902862 hasConcept C71924100 @default.
• W2000902862 hasConcept C86803240 @default.
• W2000902862 hasConceptScore W2000902862C121608353 @default.
• W2000902862 hasConceptScore W2000902862C126322002 @default.
• W2000902862 hasConceptScore W2000902862C143998085 @default.
• W2000902862 hasConceptScore W2000902862C144301174 @default.
• W2000902862 hasConceptScore W2000902862C146357865 @default.
• W2000902862 hasConceptScore W2000902862C151730666 @default.
• W2000902862 hasConceptScore W2000902862C2777658100 @default.
• W2000902862 hasConceptScore W2000902862C2778751314 @default.
• W2000902862 hasConceptScore W2000902862C2779384505 @default.
• W2000902862 hasConceptScore W2000902862C38180746 @default.
• W2000902862 hasConceptScore W2000902862C502942594 @default.
• W2000902862 hasConceptScore W2000902862C71924100 @default.
• W2000902862 hasConceptScore W2000902862C86803240 @default.
• W2000902862 hasIssue "2" @default.
• W2000902862 hasLocation W20009028621 @default.
• W2000902862 hasLocation W20009028622 @default.
• W2000902862 hasOpenAccess W2000902862 @default.
• W2000902862 hasPrimaryLocation W20009028621 @default.
• W2000902862 hasRelatedWork W1984309643 @default.
• W2000902862 hasRelatedWork W2106653639 @default.
• W2000902862 hasRelatedWork W2219852335 @default.
• W2000902862 hasRelatedWork W2373864009 @default.

• next